CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Chou, Ying Erh ^a   Hsieh, Ming Ju ^a,b   Chiou, Hui Ling ^a   Lee, Hsiang Lin ^a,c   Yang, Shun Fa ^a,c   Chen, Tzy Yen ^a,c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; CD44 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ALLELE; ARTICLE; CANCER PATIENT; CANCER RESISTANCE; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOTE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; WILD TYPE; AGED; CASE CONTROL STUDY; DISEASE PREDISPOSITION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; LIVER TUMOR; MIDDLE AGED; PATHOLOGY; RISK FACTOR; TAIWAN;

ADULT; AGED; ALLELES; ANTIGENS, CD44; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; TAIWAN;

EID: 84902164087     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/231474     Document Type: Article

References (58)

1. El-Serag H. B., Hepatocellular carcinoma. The New England Journal of Medicine 2011 365 12 1118 1127 2-s2.0-80053088189 10.1056/NEJMra1001683
2. Weng C.-J., Hsieh Y.-H., Tsai C.-M., Chu Y.-H., Ueng K.-C., Liu Y.-F., Yeh Y.-H., Su S.-C., Chen Y.-C., Chen M.-K., Yang S.-F., Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma. Annals of Surgical Oncology 2010 17 7 1808 1815 2-s2.0-77954953292 10.1245/s10434-009-0904-8
3. Farazi P. A., DePinho R. A., Hepatocellular carcinoma pathogenesis: from genes to environment. Nature Reviews Cancer 2006 6 9 674 687 2-s2.0-33747830764 10.1038/nrc1934 (Pubitemid 44286000)
4. Firpi R. J., Nelson D. R., Viral hepatitis: manifestations and management strategy. Hematology 2006 375 380 2-s2.0-34447297242
5. Yano Y., Yamashita F., Kuwaki K., Fukumori K., Kato O., Yamamoto H., Ando E., Tanaka M., Sata M., Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with α -fetoprotein and protein induced by vitamin K absence or antagonist-II. Liver International 2006 26 7 789 795 2-s2.0-33746772985 10.1111/j.1478-3231.2006.01310.x (Pubitemid 44165246)
6. Wu C.-S., Yen C.-J., Chou R.-H., Li S.-T., Huang W.-C., Ren C.-T., Wu C.-Y., Yu Y.-L., Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma. PLoS ONE 2012 7 7 2-s2.0-84863734809 10.1371/journal.pone.0039466 e39466
7. Goodison S., Urquidi V., Tarin D., CD44 cell adhesion molecules. Journal of Clinical Pathology, Molecular Pathology 1999 52 4 189 196 2-s2.0-0032768970 (Pubitemid 29369203)
8. Ponta H., Sherman L., Herrlich P. A., CD44: from adhesion molecules to signalling regulators. Nature Reviews Molecular Cell Biology 2003 4 1 33 45 2-s2.0-0037227965 10.1038/nrm1004 (Pubitemid 36077255)
9. Zöller M., CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nature Reviews Cancer 2011 11 4 254 267 2-s2.0-79953042645 10.1038/nrc3023
10. Marhaba R., Zöller M., CD44 in cancer progression: adhesion, migration and growth regulation. Journal of Molecular Histology 2004 35 3 211 231 2-s2.0-16544366235 10.1023/B:HIJO.0000032354.94213.69 (Pubitemid 40585308)
11. Hill A., McFarlane S., Johnston P. G., Waugh D. J. J., The emerging role of CD44 in regulating skeletal micrometastasis. Cancer Letters 2006 237 1 1 9 2-s2.0-33646536589 10.1016/j.canlet.2005.05.006
12. Marhaba R., Klingbeil P., Nuebel T., Nazarenko I., Buechler M. W., Zoeller M., CD44 and EpCAM: cancer-initiating cell markers. Current Molecular Medicine 2008 8 8 784 804 2-s2.0-59249094144 10.2174/156652408786733667
13. Al-Hajj M., Wicha M. S., Benito-Hernandez A., Morrison S. J., Clarke M. F., Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 2003 100 7 3983 3988 2-s2.0-0037388204 10.1073/pnas.0530291100 (Pubitemid 36418143)
14. Prince M. E., Sivanandan R., Kaczorowski A., Wolf G. T., Kaplan M. J., Dalerba P., Weissman I. L., Clarke M. F., Ailles L. E., Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proceedings of the National Academy of Sciences of the United States of America 2007 104 3 973 978 2-s2.0-33846512398 10.1073/pnas.0610117104 (Pubitemid 46154721)
15. Dalerba P., Dylla S. J., Park I.-K., Liu R., Wang X., Cho R. W., Hoey T., Gurney A., Huang E. H., Simeone D. M., Shelton A. A., Parmiani G., Castelli C., Clarke M. F., Phenotypic characterization of human colorectal cancer stem cells. Proceedings of the National Academy of Sciences of the United States of America 2007 104 24 10158 10163 2-s2.0-34547193404 10.1073/pnas.0703478104 (Pubitemid 47175279)
16. Li C., Heidt D. G., Dalerba P., Burant C. F., Zhang L., Adsay V., Wicha M., Clarke M. F., Simeone D. M., Identification of pancreatic cancer stem cells. Cancer Research 2007 67 3 1030 1037 2-s2.0-33847052127 10.1158/0008-5472.CAN- 06-2030
17. Clevers H., The cancer stem cell: premises, promises and challenges. Nature Medicine 2011 17 3 313 319 2-s2.0-79952370202 10.1038/nm.2304
18. + Cancer Stem Cells in Human Liver Cancer. Cancer Cell 2008 13 2 153 166 2-s2.0-38549139140 10.1016/j.ccr.2008.01.013 (Pubitemid 351163165)
19. Mani S. A., Guo W., Liao M.-J., Eaton E. N., Ayyanan A., Zhou A. Y., Brooks M., Reinhard F., Zhang C. C., Shipitsin M., Campbell L. L., Polyak K., Brisken C., Yang J., Weinberg R. A., The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008 133 4 704 715 2-s2.0-43049165453 10.1016/j.cell.2008.03.027 (Pubitemid 351636299)
20. Polyak K., Weinberg R. A., Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nature Reviews Cancer 2009 9 4 265 273 2-s2.0-63049123066 10.1038/nrc2620
21. Thiery J. P., Acloque H., Huang R. Y. J., Nieto M. A., Epithelial-mesenchymal transitions in development and disease. Cell 2009 139 5 871 890 2-s2.0-70450198396 10.1016/j.cell.2009.11.007
22. Yang M.-H., Chen C.-L., Chau G.-Y., Chiou S.-H., Su C.-W., Chou T.-Y., Peng W.-L., Wu J.-C., Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 2009 50 5 1464 1474 2-s2.0-72949120827 10.1002/hep.23221
23. Lee T. K., Poon R. T. P., Yuen A. P., Ling M. T., Kwok W. K., Wang X. H., Wong Y. C., Guan X., Man K., Chau K. L., Fan S. T., Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clinical Cancer Research 2006 12 18 5369 5376 2-s2.0-33749344520 10.1158/1078-0432.CCR-05-2722 (Pubitemid 44497250)
24. Chen L., Chan T. H. M., Yuan Y.-F., Hu L., Huang J., Ma S., Wang J., Dong S.-S., Tang K. H., Xie D., Li Y., Guan X.-Y., CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients. The Journal of Clinical Investigation 2010 120 4 1178 1191 2-s2.0-77951176116 10.1172/JCI40665
25. Wang S. J., Bourguignon L. Y. W., Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance. American Journal of Pathology 2011 178 3 956 963 2-s2.0-79952767543 10.1016/j.ajpath.2010.11.077
26. Mima K., Okabe H., Ishimoto T., Hayashi H., Nakagawa S., Kuroki H., Watanabe M., Beppu T., Tamada M., Nagano O., Saya H., Baba H., CD44s regulates the TGF- β -mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma. Cancer Research 2012 72 13 3414 3423 2-s2.0-84863603551 10.1158/0008-5472.CAN-12-0299
27. Okabe H., Ishimoto T., Mima K., CD44s signals the acquisition of the mesenchymal phenotype required foranchorage-independent cell survival in hepatocellular carcinoma. British Journal of Cancer 2014 110 4 958 966
28. Ji J., Wang X. W., Clinical implications of cancer stem cell biology in hepatocellular carcinoma. Seminars in Oncology 2012 39 4 461 472 2-s2.0-84864465226 10.1053/j.seminoncol.2012.05.011
29. Sauna Z. E., Kimchi-Sarfaty C., Ambudkar S. V., Gottesman M. M., Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer. Cancer Research 2007 67 20 9609 9612 2-s2.0-35448992847 10.1158/0008-5472.CAN-07-2377 (Pubitemid 47621204)
30. Morloy M., Molony C. M., Weber T. M., Devlin J. L., Ewens K. G., Spielman R. S., Cheung V. G., Genetic analysis of genome-wide variation in human gene expression. Nature 2004 430 7001 743 747 2-s2.0-4043128071 10.1038/nature02797 (Pubitemid 39071339)
31. Shastry B. S., SNP alleles in human disease and evolution. Journal of Human Genetics 2002 47 11 561 566 2-s2.0-0036955891 (Pubitemid 36083255)
32. Cheng C.-W., Su J.-L., Lin C.-W., Su C.-W., Shih C.-H., Yang S.-F., Chien M.-H., Effects of NFKB1 and NFKBIA gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathological features. PLoS ONE 2013 8 2 2-s2.0-84874015984 10.1371/journal.pone.0056130 e56130
33. Vazquez A., Grochola L. F., Bond E. E., Levine A. J., Taubert H., Müller T. H., Würl P., Bond G. L., Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3 τ and CD44 that affect sarcoma incidence and survival. Cancer Research 2010 70 1 172 180 2-s2.0-75149136548 10.1158/0008-5472.CAN-09-2218
34. Zhou J., Nagarkatti P. S., Zhong Y., Creek K., Zhang J., Nagarkatti M., Unique SNP in CD44 intron 1 and its role in breast cancer development. Anticancer Research 2010 30 4 1263 1272 2-s2.0-77953800009
35. Gerger A., Zhang W., Yang D., Bohanes P., Ning Y., Winder T., LaBonte M. J., Wilson P. M., Benhaim L., Paez D., El-Khoueiry R., El-Khoueiry A., Kahn M., Lenz H.-J., Common cancer stem cell gene variants predict colon cancer recurrence. Clinical Cancer Research 2011 17 21 6934 6943 2-s2.0-80455127294 10.1158/1078-0432.CCR-11-1180
36. Winder T., Ning Y., Yang D., Zhang W., Power D. G., Bohanes P., Gerger A., Wilson P. M., Lurje G., Tang L. H., Shah M., Lenz H.-J., Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma. International Journal of Cancer 2011 129 5 1096 1104 2-s2.0-79959703558 10.1002/ijc.25787
37. Jiang L., Deng J., Zhu X., Zheng J., You Y., Li N., Wu H., Lu J., Zhou Y., CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations. Breast Cancer Research 2012 14 4, article R105 2-s2.0-84863651864 10.1186/bcr3225
38. Yu Y.-L., Wei C.-W., Chen Y. I.-L., Chen M. H.-C., Yiang G.-T., Immunotherapy of breast cancer by single delivery with rAAV2-mediated interleukin-15 expression. International Journal of Oncology 2010 36 2 365 370 2-s2.0-75449109194 10.3892/ijo-00000508
39. Yiang G.-T., Harn H.-J., Yu Y.-L., Hu S.-C., Hung Y.-T., Hsieh C.-J., Lin S.-Z., Wei C.-W., Immunotherapy: RAAV2 expressing interleukin-15 inhibits HeLa cell tumor growth in mice. Journal of Biomedical Science 2009 16 1, article 47 2-s2.0-66649116538 10.1186/1423-0127-16-47
40. Thorgeirsson S. S., Grisham J. W., Molecular pathogenesis of human hepatocellular carcinoma. Nature Genetics 2002 31 4 339 346 2-s2.0-0036699940 10.1038/ng0802-339 (Pubitemid 35154440)
41. Weng C.-J., Tsai C.-M., Chen Y.-C., Hsieh Y.-H., Lin C.-W., Liu Y.-F., Su S.-C., Chen M.-K., Yang S.-F., Evaluation of the association of urokinase plasminogen activator system gene polymorphisms with susceptibility and pathological development of hepatocellular carcinoma. Annals of Surgical Oncology 2010 17 12 3394 3401 2-s2.0-78650980625 10.1245/s10434-010-1124-y
42. Akkiz H., Bayram S., Bekar A., Özdil B., Akgöllü E., Sümbül A. T., Demiryürek H., Doran F., G-308A TNF- α polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: Case-control study. Cancer Epidemiology 2009 33 3-4 261 264 2-s2.0-70349728447 10.1016/j.canep.2009.06.001
43. Chang C.-C., Chen S.-C., Hsieh Y.-H., Chen Y.-C., Chen T.-Y., Chu Y.-H., Ma H.-J., Chou M.-C., Tsai H.-T., Yang S.-F., Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma. Clinical Chemistry and Laboratory Medicine 2009 47 4 412 418 2-s2.0-63849320797 10.1515/CCLM.2009.092
44. Endo K., Terada T., Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival. Journal of Hepatology 2000 32 1 78 84 2-s2.0-0033962047 (Pubitemid 30039450)
45. Brown R. L., Reinke L. M., Damerow M. S., Perez D., Chodosh L. A., Yang J., Cheng C., CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. Journal of Clinical Investigation 2011 121 3 1064 1074 2-s2.0-79952227361 10.1172/JCI44540
46. Kuniyasu H., Oue N., Tsutsumi M., Tahara E., Yasui W., Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3. Clinical Cancer Research 2001 7 12 4067 4072 2-s2.0-0035674835 (Pubitemid 34044629)
47. Miyoshi T., Kondo K., Hino N., Uyama T., Monden Y., The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer. Clinical Cancer Research 1997 3 8 1289 1297 2-s2.0-0030743447 (Pubitemid 27362389)
48. Schwarz K. B., Oxidative stress during viral infection: a review. Free Radical Biology and Medicine 1996 21 5 641 649 2-s2.0-0029782304 10.1016/0891-5849(96)00131-1 (Pubitemid 26331094)
49. Mansouri A., Fromenty B., Berson A., Robin M.-A., Grimbert S., Beaugrand M., Erlinger S., Pessayre D., Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholic patients. Journal of Hepatology 1997 27 1 96 102 2-s2.0-0030806434 10.1016/S0168-8278(97)80286-3 (Pubitemid 27357061)
50. Merican I., Guan R., Amarapuka D., Alexander M. J., Chutaputti A., Chien R. N., Hasnian S. S., Leung N., Lesmana L., Phiet P. H., Sjalfoellah Noer H. M., Sollano J., Sun H. S., Xu D. Z., Chronic hepatitis B virus infection in Asian countries. Journal of Gastroenterology and Hepatology 2000 15 12 1356 1361 2-s2.0-0034526950 10.1046/j.1440-1746.2000.0150121356.x (Pubitemid 32052906)
51. Lavanchy D., Hepatitis B virus epidemiology, disease burden, treatment, arid current and emerging prevention and control measures. Journal of Viral Hepatitis 2004 11 2 97 107 2-s2.0-1642410856 10.1046/j.1365-2893.2003.00487.x (Pubitemid 38365759)
52. Kokko L.-L., Hurme S., Maula S.-M., Alanen K., Grénman R., Kinnunen I., Ventelä S., Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma. Oral Oncology 2011 47 6 510 516 2-s2.0-79958054545 10.1016/j.oraloncology.2011.03.026
53. Di Cello F., Flowers V. L., Li H., Vecchio-Pagán B., Gordon B., Harbom K., Shin J., Beaty R., Wang W., Brayton C., Baylin S. B., Zahnow C. A., Cigarette smoke induces epithelial to mesenchymal transition and increases the metastatic ability of breast cancer cells. Molecular Cancer 2013 12 1, article 90 2-s2.0-84881001606 10.1186/1476-4598-12-90
54. Zhang X. F., Wei T., Liu X. M., Liu C., Lv Y.,Impact of cigarette smoking on outcome of hepatocellular carcinoma after surgery in patients with hepatitis B. PLoS ONE 2014 9 1 e85077 10.1371/journal.pone.0085077
55. Weg-Remers S., Ponta H., Herrlich P., König H., Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway. EMBO Journal 2001 20 15 4194 4203 2-s2.0-0035421277 10.1093/emboj/20.15.4194 (Pubitemid 32751835)
56. Hofmann M., Rudy W., Gunthert U., Zimmer S. G., Zawadzki V., Zoller M., Lichtner R. B., Herrlich P., Ponta H., A link between ras and metastatic behavior of tumor cells: ras Induces CD44 promoter activity and leads to low-level expression of metastasis- specific variants of CD44 in CREF cells. Cancer Research 1993 53 7 1516 1521 2-s2.0-0027524424 (Pubitemid 23113222)
57. Strobeck M. W., DeCristofaro M. F., Banine F., Weissman B. E., Sherman L. S., Knudsen E. S., The BRG-1 subunit of the SWI/SNF complex regulates CD44 expression. The Journal of Biological Chemistry 2001 276 12 9273 9278 2-s2.0-0035937776 10.1074/jbc.M009747200
58. Reisman D. N., Strobeck M. W., Betz B. L., Sciariotta J., Funkhouser W. Jr., Murchardt C., Yaniv M., Sherman L. S., Knudsen E. S., Weissman B. E., Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression. Oncogene 2002 21 8 1196 1207 2-s2.0-0037075198 10.1038/sj/onc/1205188 (Pubitemid 34185236)